Children's Healthcare of Atlanta/Emory University

Atlanta, Georgia 30329

4 studies enrolling now · 30 studies all time

What they study most

ALL, AML, Acute Graft Versus Host Disease, Acute Leukemia of Ambiguous Lineage, Acute Liver Failure, Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Acute Undifferentiated Leukemia, Alagille Syndrome, Alpha 1-Antitrypsin Deficiency, Alpha1 Anti-Trypsin Deficiency, Asthma

Studies at this site

• Streamlined Treatment of Pulmonary Exacerbations in Pediatrics — Recruiting now
• A Prospective Database of Infants With Cholestasis — Recruiting now
• Biliary Atresia Study in Infants and Children — Recruiting now
• Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies — Recruiting now
• AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department — Stopped early
• Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC) — Paused
• Longitudinal Study of Mitochondrial Hepatopathies — Paused
• Epigenetic Reprogramming in Relapse/Refractory AML — Completed
• LCI-HEM-SCD-ST3P-UP-001: The Sickle Cell Trevor Thompson Transition Project (ST3P-UP Study) — Completed
• FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE) — Completed
• Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT — Status unconfirmed
• A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma — Completed
• BMT Autologous MSCs for GvHD — Completed
• AC220 for Children With Relapsed/Refractory ALL or AML — Completed
• A Maralixibat Expanded Access Program for Patients With Cholestatic Pruritus Associated With Alagille Syndrome (ALGS) — APPROVED_FOR_MARKETING
• Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995 — Status unconfirmed
• A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML — Completed
• Gemcabene for the Treatment of Pediatric NAFLD — Stopped early
• A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL — Stopped early
• Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL — Stopped early
• Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors — Completed
• Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass — Completed
• Dose-Finding Study of SC411 in Children With Sickle Cell Disease — Status unconfirmed
• POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients — Completed
• G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome — Stopped early
• A Safety Study of SGN-CD19A for Leukemia and Lymphoma — Completed
• A Study Of Panobinostat In Children With Refractory Hematologic Malignancies — Completed
• Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT) — Completed
• Curative Versus Disease-Modifying Therapies in Children With Severe Sickle Cell Disease — Completed
• GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease — Completed